See our exclusive July offer Click Here

See our exclusive July offer Click Here

Non-invasive 40-Hz Light Flicker Ameliorates Alzheimer’s-Associated Rhythm Disorder via Regulating Central Circadian Clock in Mice

Optoceutics Woman laying down holding her head
Publication: National Library of Medicine
Authors: Youli Yao, Ying Ying, Qiyu Deng, Wenjiang Zhang, Huazhang Zhu, Zhenglong Lin, Shengli Zhang, Junxian Ma, and Yingying Zhao

The article titled “Prognosis for Cardiogenic Shock Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO) Treatment” explores the critical role of ECMO in managing cardiogenic shock (CS), a life-threatening condition characterized by severe reduction in cardiac output. ECMO serves as a mechanical circulatory support system that can significantly improve survival rates for these patients.

Cardiogenic shock often arises from acute myocardial infarction and other severe cardiac conditions, leading to high mortality rates. ECMO, particularly veno-arterial ECMO (VA-ECMO), supports the heart and lungs by oxygenating the blood outside the body, thus allowing the heart to rest and recover. This intervention is crucial in stabilizing patients who are not responding to conventional therapies.

The article delves into various studies and clinical trials that demonstrate the efficacy of ECMO in improving survival rates and outcomes for CS patients. It highlights that timely initiation of ECMO is associated with better prognoses, including higher rates of successful weaning off the machine and discharge from the hospital. For instance, one study mentioned a survival rate of 75% for patients who received preoperative ECMO support​ (SpringerOpen)​​ (BioMed Central)​.

Additionally, the article discusses the complex balance required in managing antithrombotic therapy during ECMO treatment due to the heightened risks of both thrombosis and bleeding. Personalized treatment plans and continuous monitoring are emphasized to optimize outcomes​ (MDPI

In summary, ECMO provides a life-saving option for patients in cardiogenic shock, with evidence supporting its effectiveness in improving short-term and long-term outcomes. For those interested in advanced cardiac care and the latest in ECMO therapy, this article offers valuable insights and underscores the importance of early intervention and meticulous management in critically ill patients. I highly recommend reading the full article to gain a comprehensive understanding of the advancements and challenges in treating cardiogenic shock with ECMO. 

You can access the full article here

Learn What Others Have Experienced with EVY Light

See how others have achieved a sharper mind by activating their gamma brainwaves in combination with maintaining a healthy lifestyle.

2560 1338 Christopher Ravn

Receive notification when news, blogs, promotions, or other valuable information drops

OC logo gold

Get exclusive content straight from the scientists who are rooting for you and your brain.

    Be the first to know about new developments from your favorite products
    Optoceutics logo word mark blue

    EVY LIGHT ® Is Your Ultimate Brain
    Wellness Device

    Comfortable Daily Use, Drug Free to Promote Focus, Clarity, and Mental Sharpness.

    OC logo gold

    Get exclusive content straight from the scientists who are rooting for you and your brain.

      Be the first to know about new developments from your favorite products
      Privacy Preferences

      When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

      Click to enable/disable Google Analytics tracking code.
      Click to enable/disable Google Fonts.
      Click to enable/disable Google Maps.
      Click to enable/disable video embeds.
      Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.